Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial. - Trauner M; Levy C; Tanaka A; Goodman Z; Thorburn D; Joshi D; Salminen K; Yimam K; Isayama H; Montano-Loza AJ; Caldwell S; Danta M; et al. (The lancet. Gastroenterology & hepatology, 2026)